HIV Drug Development Challenge: Will Patients Accept Risk Of Cure?
This article was originally published in The Pink Sheet Daily
Executive Summary
The second of FDA’s 20 patient-focused drug development meetings will tackle barriers to patient enrollment in HIV cure studies and current gaps in HIV therapy.